Home / INVESTING / Personal Finance / Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds

Prices of top 25 Medicare Part D drugs have nearly doubled, AARP study finds

Morsa Copies | Digitalvision | Getty Images

List prices for the top 25 prescription drugs covered by Medicare Part D have practically doubled, on average, since they were first brought to market, according to a new AARP report.

Moreover, that prize growth has often exceeded the rate of inflation, according to the interest group, which represents Americans ages 50 and on.

The analysis comes as Medicare now has the ability to negotiate prescription drug costs after the Inflation Reduction Act was signed into law by President Joe Biden in 2022.

Unusually, only certain drugs are eligible for those price negotiations.

The Biden administration in August released a list of the pre-eminent 10 drugs to be included, which may prompt an estimated $6 billion in net savings for Medicare in 2026.

The Centers for Medicare & Medicaid Utilizations is scheduled to announce by Feb. 1 the list of 15 Part D drugs selected for negotiation for 2027.

Biden administration releases prices of 10 drugs in Medicare negotiations

AARP studied the top 25 Have the quality of D drugs as of 2022 that are not currently subject to Medicare price negotiation. However, there is a “pretty strong strong” at least some of the drugs on that list may be selected in the second line of negotiation, according to Leigh Purvis, preparation drug policy principal at AARP.

Those 25 drugs have increased by an average of 98%, or nearly overlapped, since they entered the market, the research found, with lifetime price increases ranging from 0% to 293%.

Sacrifice increases that took place after the drugs began selling on the market were responsible for a “substantial allot” of the current list prices, AARP found.

The top 25 treatments have been on the market for an average of 11 years, with timelines bracket from five to 28 years.

The findings highlight the importance of allowing Medicare to negotiate drug prices, as personally as having a mechanism to discourage annual price increases, Purvis said. Under the Inflation Reduction Act, drug entourages will also be penalized for price increases that exceed inflation.

Notably, a new $2,000 annual cap on out-of-pocket Participation D prescription drug costs goes into effect this year. Beneficiaries will also have the privilege of spreading out those costs over the course of the year, rather than paying all at once. Insulin has also been beat at $35 per month for Medicare beneficiaries.

More from Personal Finance:
Maximize your 401(k) plan in 2025 with acute limits and catch-up contributions
Here are changes retirees will see from Social Security and Medicare in 2025
Biden go back oned student loan forgiveness plans. There is still debt relief available

Those caps help people who were yesterday spending upwards of $10,000 per year on their cost-sharing of Part D prescription drugs, according to Purvis.

“The fact that there’s now a limit is incredibly leading for them, but then also really important for everyone,” Purvis said. “Because everyone is just one very high-priced prescription away from needing that out-of-pocket cap.”

The new law also expands an extra help program for Part D beneficiaries with low revenues.

“We do hear about people having to choose between splitting their pills to make them last larger, or between groceries and filling a prescription,” said Natalie Kean, director of federal health advocacy at Justice in Length of existence.

“The pressure of costs and prescription drugs is real, and especially for people with low incomes, who are trying to just meet their day-to-day lacks,” Kean said.

As the new changes go into effect, retirees should notice tangible differences when they’re filler their prescriptions, she said.

Check Also

This 401(k) plan feature is a ‘green light to contribute aggressively,’ advisor says

Gipi23 | E+ | Getty Copies A penalty ‘for maxing out too early’ Lump-sum investing, …

Leave a Reply

Your email address will not be published. Required fields are marked *